Categories
Biden Pandemic COVID Links from other news sources.

Why? Stanford Study of Paxlovid for Long COVID Stopped Early.

Visits: 18

Why? Stanford Study of Paxlovid for Long COVID Stopped Early. Enrollment was halted earlier than planned after intern analysis. We have this from MedPage Today. No reasons were given.

Enrollment into a small trial of nirmatrelvir/ritonavir (Paxlovid) for long COVID — one that previously garnered attention for investigators not wearing masksopens in a new tab or window — has been stopped early after an interim analysis, Stanford University confirmed to MedPage Today.

Two sources familiar with the STOP-PASC studyopens in a new tab or window told MedPage Today that trial enrollment had been halted. One was told by a study coordinator that a preliminary review found “inconclusive evidence” for the primary outcome of the study. Another said their first appointment was canceled just a few days before it was supposed to take place, and they were later told that all future enrollment had been halted.

Why was the study stopped? Or was it?

Complete article is here.

Loading

78

By MC

Master of Truth. A writer who has captured the imagination of many.

Verified by MonsterInsights